Form 8-K - Current report:
SEC Accession No. 0001656472-24-000054
Filing Date
2024-04-25
Accepted
2024-04-25 16:30:16
Documents
29
Period of Report
2024-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cron-20240425.htm   iXBRL 8-K 32577
2 EX-10.1 exhibt101-cronosxaltriav.htm EX-10.1 40693
7 exhibt101-cronosxaltriav001.jpg GRAPHIC 225973
8 exhibt101-cronosxaltriav002.jpg GRAPHIC 265450
9 exhibt101-cronosxaltriav003.jpg GRAPHIC 271638
10 exhibt101-cronosxaltriav004.jpg GRAPHIC 286127
11 exhibt101-cronosxaltriav005.jpg GRAPHIC 255842
12 exhibt101-cronosxaltriav006.jpg GRAPHIC 268509
13 exhibt101-cronosxaltriav007.jpg GRAPHIC 266845
14 exhibt101-cronosxaltriav008.jpg GRAPHIC 101495
15 exhibt101-cronosxaltriav009.jpg GRAPHIC 255081
16 exhibt101-cronosxaltriav010.jpg GRAPHIC 247941
17 exhibt101-cronosxaltriav011.jpg GRAPHIC 302575
18 exhibt101-cronosxaltriav012.jpg GRAPHIC 43534
19 exhibt101-cronosxaltriav013.jpg GRAPHIC 40032
20 exhibt101-cronosxaltriav014.jpg GRAPHIC 57947
  Complete submission text file 0001656472-24-000054.txt   4201727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cron-20240425.xsd EX-101.SCH 2177
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cron-20240425_def.xml EX-101.DEF 2890
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cron-20240425_lab.xml EX-101.LAB 23477
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cron-20240425_pre.xml EX-101.PRE 13632
33 EXTRACTED XBRL INSTANCE DOCUMENT cron-20240425_htm.xml XML 2996
Mailing Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1
Business Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1 (416) 504-0004
Cronos Group Inc. (Filer) CIK: 0001656472 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38403 | Film No.: 24876841
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)